Pipeline

Français
Program Indication Program Stage Commercial Rights
 
Clinical Pipeline
IVA337
  • NASH,  SSc
  • Phase IIb
 Inventiva
IVA336
  • MPS I, MPS II,  MPS VI
  • Phase I/II
 Inventiva
Preclinical Pipeline
YAP/TEAD
  • Malignant Mesothelioma, Lung Cancer
  • Discovery
 Inventiva
NSD2
  • Multiple Myeloma
  • Discovery
 Inventiva
EPICURE
  • Immuno-oncology
  • Research
Inventiva
AbbVie Collaboration
Undisclosed target
Undisclosed targets
  • Auto-Immune Disorders
  • Fibrosis
  • Phase I
  • Discovery
 abbvie
Boehringer-Ingelheim collaboration
Undisclosed target
  • Fibrosis
  • Discovery